228 related articles for article (PubMed ID: 18220763)
41. Oral anti-diabetic drugs for the prevention of Type 2 diabetes.
Phung OJ; Sood NA; Sill BE; Coleman CI
Diabet Med; 2011 Aug; 28(8):948-64. PubMed ID: 21429006
[TBL] [Abstract][Full Text] [Related]
42. Are you up-to-date on diabetes medications?
Scemons D
Nursing; 2007 Jul; 37(7):45-9; quiz 49-50. PubMed ID: 17603373
[TBL] [Abstract][Full Text] [Related]
43. Oral diabetes medications: an update for home health clinicians.
Jacobs JA; Fetzer SJ
Home Healthc Nurse; 2013 Jan; 31(1):E1-13. PubMed ID: 23238625
[TBL] [Abstract][Full Text] [Related]
44. Oral antihyperglycaemics. Considerations in older patients with non-insulin-dependent diabetes mellitus.
Jennings PE
Drugs Aging; 1997 May; 10(5):323-31. PubMed ID: 9143853
[TBL] [Abstract][Full Text] [Related]
45. [Combination therapy with biguanides].
Sakura H
Nihon Rinsho; 2002 Oct; 60 Suppl 10():724-8. PubMed ID: 12430309
[No Abstract] [Full Text] [Related]
46. A systematic review of acute pancreatitis as an adverse event of type 2 diabetes drugs: from hard facts to a balanced position.
Giorda CB; Nada E; Tartaglino B; Marafetti L; Gnavi R
Diabetes Obes Metab; 2014 Nov; 16(11):1041-7. PubMed ID: 24702687
[TBL] [Abstract][Full Text] [Related]
47. Oral antihyperglycemic agents during pregnancy and lactation: a review.
Merlob P; Levitt O; Stahl B
Paediatr Drugs; 2002; 4(11):755-60. PubMed ID: 12390047
[TBL] [Abstract][Full Text] [Related]
48. [Knack of treatment with oral hypoglycemic drugs in the elderly].
Komatsu M; Hashizume K
Nihon Rinsho; 2006 Jan; 64(1):93-8. PubMed ID: 16408454
[TBL] [Abstract][Full Text] [Related]
49. Should Side Effects Influence the Selection of Antidiabetic Therapies in Type 2 Diabetes?
Grunberger G
Curr Diab Rep; 2017 Apr; 17(4):21. PubMed ID: 28293908
[TBL] [Abstract][Full Text] [Related]
50. Complications of diabetes therapy.
Corathers SD; Peavie S; Salehi M
Endocrinol Metab Clin North Am; 2013 Dec; 42(4):947-70. PubMed ID: 24286957
[TBL] [Abstract][Full Text] [Related]
51. Pioglitazone + glimepiride: a combination product to avoid.
Prescrire Int; 2007 Aug; 16(90):145. PubMed ID: 17724836
[No Abstract] [Full Text] [Related]
52. Biguanides. Mode of action and role in the up-to-date treatment of diabetes mellitus.
Fövényi J
Ther Hung; 1971; 19(2):43-8. PubMed ID: 5172874
[No Abstract] [Full Text] [Related]
53. Which oral drug is right for your type 2 diabetes? New thinking on oral drug combinations that can provide better glycemic control.
Health News; 2005 Feb; 11(2):10-1. PubMed ID: 15732153
[No Abstract] [Full Text] [Related]
54. [Oral antidiabetic agents: what are the choices?].
Crausaz FM
Rev Med Suisse Romande; 1991 Aug; 111(8):701-5. PubMed ID: 1925244
[No Abstract] [Full Text] [Related]
55. [Adverse effects of oral hypoglycemic agents].
Mori Y; Sekihara H
Nihon Rinsho; 2002 Sep; 60 Suppl 9():325-31. PubMed ID: 12387013
[No Abstract] [Full Text] [Related]
56. [Exploring an optimal approach to the use of oral hypoglycemic agents based on CGM results: implications for combination therapy with oral hypoglycemic agents].
Mori Y
Nihon Rinsho; 2011 Aug; 69(8):1505-14. PubMed ID: 21838054
[TBL] [Abstract][Full Text] [Related]
57. Pharmacotherapy of type 2 diabetes mellitus.
Rendell MS; Kirchain WR
Ann Pharmacother; 2000; 34(7-8):878-95. PubMed ID: 10928401
[TBL] [Abstract][Full Text] [Related]
58. Initial metformin or sulphonylurea exposure and cancer occurrence among patients with type 2 diabetes mellitus.
Qiu H; Rhoads GG; Berlin JA; Marcella SW; Demissie K
Diabetes Obes Metab; 2013 Apr; 15(4):349-57. PubMed ID: 23137378
[TBL] [Abstract][Full Text] [Related]
59. Genetic polymorphisms in diabetes: influence on therapy with oral antidiabetics.
Glamočlija U; Jevrić-Čaušević A
Acta Pharm; 2010 Dec; 60(4):387-406. PubMed ID: 21169132
[TBL] [Abstract][Full Text] [Related]
60. Pioglitazone hydrochloride/glimepiride.
Blake EW
Drugs Today (Barc); 2007 Jul; 43(7):487-97. PubMed ID: 17728849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
